Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2026-02-25 @ 4:15 AM
Study NCT ID:
NCT01715402
Status:
UNKNOWN
Last Update Posted:
2017-02-06
First Post:
2012-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Optimization of Health Expenditure in Liver Surgery
Sponsor:
Centre Hospitalier Universitaire, Amiens
Organization:
Study Overview
Official Title:
Optimization of Health Expenditure in Major Surgery: Impact of a Mixed, Clinical and Ethnographic Approach in the Model of Liver Surgery
Status:
UNKNOWN
Status Verified Date:
2017-02
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to reduce the length of stay after liver surgery by taking account of objective quantitative clinical variables, subjective qualitative clinical variables and non clinical variables.
Detailed Description:
a new dimension of the activity expected of physicians is to improve the safety of care on the one hand and the control of health care costs on the other.
key measures to help them are the publication of national recommendations, assessment of actual practices and the incentive to activity.
Internationalwide recent and concordant data suggest that
* quality and security of care, after an initial improvement, are going to stall
* scientific recommendations are rarely validated by an impact analysis and are not applied
* clinical data collected within an administrative framework are unreliable and too generalist
* the evaluation, especially in the surgical field, is based on indicators sometimes irrelevant and often unclear
key measures to help them are the publication of national recommendations, assessment of actual practices and the incentive to activity.
Internationalwide recent and concordant data suggest that
* quality and security of care, after an initial improvement, are going to stall
* scientific recommendations are rarely validated by an impact analysis and are not applied
* clinical data collected within an administrative framework are unreliable and too generalist
* the evaluation, especially in the surgical field, is based on indicators sometimes irrelevant and often unclear
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: